SCHEMBL7754483

SCHEMBL7754483

Cc1cnn(-c2cc(N)c(Cl)cc2Cl)c(=O)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
PAX8 Q06710 1/20 0.35
FGFR1 P11362 1/20 0.34
SRC P12931 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR4 P22455 1/20 0.34
FGFR3 P22607 1/20 0.34
KDR P35968 1/20 0.34
ALDH1A1 P00352 2/20 0.33
KMT2A Q03164 1/20 0.33
GAA P10253 1/20 0.32
NPBWR1 P48145 3/20 0.32
MCHR1 Q99705 2/20 0.32
HCAR1 Q9BXC0 1/20 0.31
LMNA P02545 2/20 0.30
NPSR1 Q6W5P4 2/20 0.30
ALOX12 P18054 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7755931 0.77 PKM (0.43) MAPTALDH1A1KMT2ALMNANPSR1
SCHEMBL4064696 0.77 HTT (0.46) MAPTNPC1RAB9APAX8FGFR1
SCHEMBL5844822 0.75 RAB9A (0.35) MAPTTP53NPC1RAB9APAX8
SCHEMBL3342293 0.75 HSD17B10 (0.34) NPC1RAB9AKMT2AHTT
SCHEMBL4062470 0.70 NPBWR1 (0.42) NPC1RAB9APAX8ALDH1A1KMT2A
SCHEMBL3346925 0.68 MAPT (0.42) MAPTNPC1RAB9APAX8ALDH1A1
SCHEMBL3342417 0.68 CA12 (0.38) MAPTNPC1RAB9APAX8FGFR1
SCHEMBL29387767 0.66 PPOX (0.63)
SCHEMBL3195403 0.66 PPOX (0.63)
SCHEMBL10413922 0.66 P2RX7 (0.34) MAPTTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1070055-A1 SUBSTITUTED PHENYL PYRIDAZINONES Bayer Aktiengesellschaft (DE) 2001-01-24 EP disclosed
WO-1999052878-A1 SUBSTITUTED PHENYL PYRIDAZINONES BAYER AKTIENGESELLSCHAFT (DE) 1999-10-21 WO disclosed